  Effective and rapid decision-making from randomized controlled trials (RCTs)
requires unbiased and precise treatment effect inferences. Two strategies to
address this requirement are to adjust for covariates that are highly
correlated with the outcome, and to leverage historical control information via
Bayes' theorem. We propose a new Bayesian prognostic covariate adjustment
methodology, referred to as Bayesian PROCOVA, that combines these two
strategies. Covariate adjustment in Bayesian PROCOVA is based on generative
artificial intelligence (AI) algorithms that construct a digital twin generator
(DTG) for RCT participants. The DTG is trained on historical control data and
yields a digital twin (DT) probability distribution for each RCT participant's
outcome under the control treatment. The expectation of the DT distribution,
referred to as the prognostic score, defines the covariate for adjustment.
Historical control information is leveraged via an additive mixture prior with
two components: an informative prior probability distribution specified based
on historical control data, and a weakly informative prior distribution. The
mixture weight determines the extent to which posterior inferences are drawn
from the informative component, versus the weakly informative component. This
weight has a prior distribution as well, and so the entire additive mixture
prior is completely pre-specifiable without involving any RCT information. We
establish an efficient Gibbs algorithm for sampling from the posterior
distribution, and derive closed-form expressions for the posterior mean and
variance of the treatment effect parameter conditional on the weight, in
Bayesian PROCOVA. We evaluate efficiency gains of Bayesian PROCOVA via its bias
control and variance reduction compared to frequentist PROCOVA in simulation
studies that encompass different discrepancies. These gains translate to
smaller RCTs.
